GalaFLEX Mesh Problems: What Patients Are Reporting

GalaFLEX mesh, manufactured by Galatea Surgical (now part of Becton, Dickinson and Company), is a bioresorbable surgical mesh made from a polymer called P4HB (poly-4-hydroxybutyrate). It is marketed as a "soft tissue scaffold" to support and reinforce tissues in breast reconstruction, revision, and cosmetic surgeries. While promoted as a revolutionary product that provides strong support before safely dissolving, a growing number of patients and surgeons are reporting significant complications.

The Promise vs. The Reality of Resorption

The core marketing claim for GalaFLEX is that it provides robust support for about 12-18 months, stimulating the body to build its own new layer of collagen, and then fully resorbs over about two years, leaving behind stronger native tissue. The ideal scenario is that the mesh acts as a temporary internal bra that disappears once the body has healed.

However, the central allegation in emerging litigation is that the mesh often degrades and loses its structural integrity much faster than advertised. When the mesh weakens prematurely, before the body has formed a sufficiently strong collagen layer, the support is lost. This can lead to a cascade of problems, including implant malposition and recurrent sagging, often requiring complex revision surgery.

Commonly Reported GalaFLEX Complications

Patient reports and surgical findings have highlighted several recurring problems associated with GalaFLEX mesh:

• Premature Mesh Failure: The most common complaint is that the mesh stretches, thins, or breaks down too quickly, leading to a loss of support for the breast implant or tissue. This can result in the implant "bottoming out" or shifting position.
• Severe Inflammatory Reactions: Some patients experience a prolonged and intense inflammatory response to the P4HB material or its breakdown products. This can cause chronic pain, persistent swelling, and redness that does not resolve with standard post-operative care.
• Capsular Contracture: While capsular contracture is a known risk of any implant surgery, some surgeons have reported observing unusually aggressive or rapid capsular contracture in breasts where GalaFLEX mesh was used, potentially linked to the inflammatory response it provokes.
• Chronic Pain: Persistent, sharp, or burning pain that lasts for months or years after surgery. This may be due to nerve irritation from the mesh or chronic inflammation.
• Palpable or Visible Mesh: In patients with thin tissue, the texture or edges of the mesh can sometimes be felt or even seen through the skin, creating an unnatural contour.
• Infection and Seroma: The mesh can increase the risk of post-operative infection or the formation of a seroma (a pocket of fluid), which can compromise the surgical result and may require drainage or even removal of the implant and mesh.
• Need for Revision Surgery: Ultimately, many of these complications necessitate one or more revision surgeries to remove the failed mesh, reposition the implant, and address the resulting tissue damage. Revision surgeries are often more complex and costly than the original procedure.

The FDA 510(k) Clearance Pathway

GalaFLEX did not go through the FDA's most rigorous Premarket Approval (PMA) process, which is reserved for high-risk devices. Instead, it came to market via the 510(k) pathway. This process only requires the manufacturer to show that the new device is "substantially equivalent" to a device already on the market (a "predicate device").

The 510(k) process does not typically require extensive clinical trial data proving safety and effectiveness in the specific way the device will be used. Critics and plaintiffs in litigation argue that this regulatory shortcut allowed a novel material to be widely used in complex breast surgeries without adequate long-term clinical evidence to back up its marketing claims about durability and resorption time.

What to Do if You Have GalaFLEX Mesh

If you have GalaFLEX mesh and are not experiencing problems, no immediate action is required beyond your standard follow-up care. However, if you are experiencing any of the symptoms of mesh failure described above, it is crucial to:

1. See Your Surgeon: Schedule an evaluation to diagnose the cause of your symptoms.
2. Obtain Your Operative Report: This is the key document that confirms exactly what product was implanted.
3. Document Your Symptoms: Keep a detailed log with dates and photos to track the progression of your complications.
4. Consider a Legal Consultation: If your surgeon confirms a mesh-related complication requiring revision surgery, speak with an attorney who specializes in medical device litigation. They can evaluate your case and advise you on your legal options.

Related Pages on This Site

• Signs of Breast Mesh Failure
• Understanding FDA 510(k) Clearance
• Check Your Eligibility